ROBERT HOFFMAN Insider Trading $MBVX MABVAX THERAPEUTICS HOLDINGS, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ROBERT HOFFMAN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ROBERT HOFFMAN. ROBERT HOFFMAN is CFO & SVP, Finance in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and CFO & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and SVP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance & CAO in ARENA PHARMACEUTICALS INC ($ARNA) and VP, Finance and CFO in ARENA PHARMACEUTICALS INC ($ARNA) and in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX) and Director in CombiMatrix Corp ($CBMX) and CHIEF FINANCIAL OFFICER in INNOVUS PHARMACEUTICALS, INC. ($INNV) and Director in Kura Oncology, Inc. ($KURA) and Director in DelMar Pharmaceuticals, Inc. ($DMPI) and Director in Aravive, Inc. ($VSAR).

ROBERT HOFFMAN in MABVAX THERAPEUTICS HOLDINGS, INC.

Trading Symbol: MBVX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ROBERT HOFFMAN:
Holdings: 4,438 shares
Current Value: $13,181
Latest Transaction: May 23 2017
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97

Last 4 weeks trend: BUY
Last 3 months trend: STRONG BUY

Last 3 Months Overview:
Buy: 2x
Sell: 0x
Shares Bought: 12,960
Shares Sold: 0
Share Difference: +12,960
Value Difference: $0

Latest Insider Trading Transactions of ROBERT HOFFMAN in MABVAX THERAPEUTICS HOLDINGS, INC.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ARAV, ARNA, CBMX, HRTX, INNV, KTRA, KURA, MBVX

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 23 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA1.8050,00090,00050,000
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseM0.001,54301,543
Apr 04 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTBuyM0.001,54304,4382.9 K to 4.4 K (+53.30 %)
Jan 03 2017MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA3.384,10013,8584,100
Aug 30 2016MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA5.004,10020,5004,100
Jul 28 2016MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA0.5535,00019,25035,000
Apr 05 2016MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseM0.0011,417022,833
Apr 05 2016MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTBuyM0.0011,417021,41710 K to 21.4 K (+114.17 %)
Aug 27 2015MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTOption ExerciseA1.5235,00053,20035,000
Apr 03 2015MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTDirectorOption ExerciseA0.0034,250034,250
Apr 03 2015MBVXMABVAX THERAPEUTIC ...HOFFMAN ROBERTDirectorOption ExerciseA2.3034,25078,77534,250

Page:   1